[Early-onset Colorectal Cancer: Epidemiological and Clinical Characteristics and Survival Analysis in a Hospital Cohort]. [PDF]
Balmaceda R +5 more
europepmc +1 more source
[[Supravalvular pulmonary stenosis as a manifestation of a mediastinal germ cell tumor: a case report]]. [PDF]
García-Saavedra MB +7 more
europepmc +1 more source
[Clinical spectrum, neuroimaging and therapeutic response to neurological syndromes associated with anti-GAD65]. [PDF]
Hernández-Salomón LF +5 more
europepmc +1 more source
[Long-term outcomes of maxillectomy for paranasal sinus cancer]. [PDF]
Ramírez-Echavarría A +4 more
europepmc +1 more source
[Neuroendocrine expression markers in triple-negative, luminal-A, luminal-B and HER2neu breast cancer]. [PDF]
Barboza-García YG +4 more
europepmc +1 more source
[Pattern of invasive growth of pituitary adenomas with positive hormonal immunohistochemistry]. [PDF]
Bello-Lemus VH +2 more
europepmc +1 more source
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107). [PDF]
Garcia-Carbonero R +24 more
europepmc +1 more source
[Solid Pseudopapillary Neoplasm of the Pancreas: Diagnosis and Surgical Management in a Young Patient]. [PDF]
García Alba EL +6 more
europepmc +1 more source
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914). [PDF]
Capdevila J +19 more
europepmc +1 more source
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial. [PDF]
Capdevila J +41 more
europepmc +1 more source

